Thus, the treatment of cancer patients with PD-1 inhibitors results in the have been demonstrated to directly induce Interferon γ (IFN-γ) production of activated T cells, release of IL-12 by intra-tumor dendritic cells subpopulations [251,252]. This evidence concerns the gene PDCD1 and neoplasm.